Birdwatch Note Rating
2023-03-15 21:45:46 UTC - NOT_HELPFUL
Rated by Participant: 622DCF2DE98CF56BAD09A65211132962D76125249ED6936BE43C6824EFC2C1B2
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details